Breast Cancer

One expert explained the common side effects at every line of treatment for metastatic HER2-positive breast cancer during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

My oncologist said that having a supportive community during cancer is just as important as treatment and I could not agree more — it makes me thankful.

My health care team went back and forth on whether spots on my liver were cancerous, and that put me on an emotional rollercoaster.

Being a part of the cancer community means meeting new people, forming personal friendships and fostering those connections for others.

My reliable primary care physician was such an important asset in navigating multiple cancers.

Having my metastatic breast cancer experience turned into a piece of art was such a meaningful opportunity.

Patients who received systemic therapy at the end of life did not have longer overall survival averages than those who did not receive therapy at end of life.

After having breast cancer, I worked on learning to accept and love myself.

From Kate Middleton giving an update on her cancer treatment to Kevin Jonas’ skin cancer surgery, here’s what’s happening in the oncology space this week.

Having social media platforms to share breast cancer experiences changes the narrative for others who may empathize, a survivor and advocate said.

Through it all, poetry was the lens through which I could examine and deal with these very emotional and painful times in my life.

It’s important for cancer survivors to follow-up with things that worry them. For me, my lymphedema sparked some fear.

I believe I have hereditary cancer, especially after my daughter was approved to receive genetic testing for breast cancer.

After a good friend told me about her recent diagnosis of breast cancer, I started experiencing a type of breast cancer déjà vu.

Enhertu lengthened the time to progression in patients with HR-positive, HER2-low or -ultralow metastatic breast cancer.

From NBA Hall of Famer Bill Walton dying from cancer to an ancient skull showing evidence of early cancer treatments, here’s what’s happening in the oncology space this week.

The priority review is based on findings from a study that found that inavolisib reduced the risk for disease progression or death by 57%.

I didn’t know that there were many kinds of breast cancer or how obsessed people were with hair.

In a group of breast cancer survivors, 73% who attempted pregnancy were successful, though there were certain characteristics associated with an increased chance of getting pregnant.

The Food and Drug Administration granted a breakthrough therapy designation to inavolisib plus Ibrance and fulvestrant for HR-positive, HER2-negative locally advanced or metastatic breast cancer.

Aerobic and strength training exercises may help preserve physical functioning in older adults with early-stage breast cancer who received chemotherapy.

With my breast cancer experience, there's always a juxtaposition between the fear of mortality and the hope of living.

When I received news of a fellow blogger’s demise, I was heartbroken.

Safety data further support datopotamab deruxtecan as a new treatment option in metastatic hormone receptor–positive, HER2-negative breast cancer.

My relationship with my body has changed over the years, especially during and after breast cancer. Now, I have accepted the way I look.

Adding Truqap to Faslodex improved outcomes in patients with locally advanced or metastatic HR-positive, HER2-negative breast cancer.

From Olivia Munn opening up about undergoing a hysterectomy and egg retrieval to Michael McDonald’s learned lesson after his wife’s cancer, here’s what’s going on in the oncology space this week.

The addition of Tecentriq to chemotherapy did not improve overall survival in patients with relapsed triple-negative breast cancer.

This poem is a reflection of some of my thoughts and feelings when my wife received a diagnosis of triple-negative breast cancer.

I believe a divine intervention miraculously saved my life when I had a dream about breast cancer — it turned out to be true.